뭔가 하고 싶은 말이 있는거야?
컨텐츠 내용을 수정할 수 있습니다
| Drug | Mechanism | Major Contraindication | Key Benefit |
|---|---|---|---|
| Cilostazol | PDE inhibitor | Heart failure | Most effective for claudication |
| Pentoxifylline | Rheologic modifier | Recent cerebral/retinal hemorrhage | Safer cardiac profile |
| Isoxsuprine | Direct vasodilator | Arterial bleeding | Rapid onset |
A 68-year-old patient with PAD reports leg cramping after walking one block. After starting cilostazol, what should the nurse monitor? Answer: Blood pressure for hypotension, heart rate for arrhythmias, walking tolerance improvement, and any signs of heart failure exacerbation.
| Aspect | Peripheral Vasodilators | Anticoagulants |
|---|---|---|
| Primary Action | Dilate blood vessels | Prevent clot formation |
| Bleeding Risk | Minimal | Significant |
| Monitoring | BP, circulation | PT/INR, bleeding |
| Reversal Agent | None needed | Specific antidotes available |
FLOW (Vasodilators): Focus on vessel dilation
CLOT (Anticoagulants): Focus on clotting prevention
다음 이론을 계속 학습하려면 로그인하세요.
로그인하고 계속 학습필기노트, 하이라이터, 메모는 잘 쓰고 있어?
내보내줘운영진이 검토할게요!
마이페이지에서 차단한 회원을 관리할 수 있어요.